These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15824161)

  • 1. Safety and efficacy of weekly oral oltipraz in chronic smokers.
    Kelley MJ; Glaser EM; Herndon JE; Becker F; Bhagat R; Zhang YJ; Santella RM; Carmella SG; Hecht SS; Gallot L; Schilder L; Crowell JA; Perloff M; Folz RJ; Bergan RC
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):892-9. PubMed ID: 15824161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.
    Izzotti A; Balansky RM; Dagostini F; Bennicelli C; Myers SR; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 2001 Mar; 61(6):2472-9. PubMed ID: 11289117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic dosing of oltipraz in people at increased risk for colorectal cancer.
    Szarka CE; Yao KS; Pfeiffer GR; Balshem AM; Litwin S; Frucht H; Goosenberg EB; Engstrom PF; Clapper ML; O'Dwyer PJ
    Cancer Detect Prev; 2001; 25(4):352-61. PubMed ID: 11531012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies.
    Dimitrov NV; Leece CM; Tompkins ER; Seymour E; Bennink M; Gardiner J; Crowell J; Hawk E; Nashawaty M; Bennett JL
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):201-7. PubMed ID: 11303588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oltipraz: a laboratory and clinical review.
    Benson AB
    J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; van Zandwijk N; Wigbout G; Qian GS; Zhu YR; Kensler TW
    J Cell Biochem Suppl; 1996; 25():92-8. PubMed ID: 9027604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population.
    Pavanello S; Pulliero A; Saia BO; Clonfero E
    Mutat Res; 2006 Dec; 611(1-2):54-63. PubMed ID: 16978913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
    Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
    Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cigarette smoke-related lipophilic DNA adducts in rat tissues by dietary oltipraz.
    Arif JM; Gairola CG; Glauert HP; Kelloff GJ; Lubet RA; Gupta RC
    Carcinogenesis; 1998 Aug; 19(8):1515-7. PubMed ID: 9744551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
    Van Schooten FJ; Besaratinia A; De Flora S; D'Agostini F; Izzotti A; Camoirano A; Balm AJ; Dallinga JW; Bast A; Haenen GR; Van't Veer L; Baas P; Sakai H; Van Zandwijk N
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):167-75. PubMed ID: 11867504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
    Jacobson LP; Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Yu LY; Qian GS; Kuang SY; Li YF; Fang X; Zarba A; Chen B; Enger C; Davidson NE; Gorman MB; Gordon GB; Prochaska HJ; Egner PA; Groopman JD; Muñoz A; Helzlsouer KJ; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):257-65. PubMed ID: 9107431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.
    Wang JS; Shen X; He X; Zhu YR; Zhang BC; Wang JB; Qian GS; Kuang SY; Zarba A; Egner PA; Jacobson LP; Muñoz A; Helzlsouer KJ; Groopman JD; Kensler TW
    J Natl Cancer Inst; 1999 Feb; 91(4):347-54. PubMed ID: 10050868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts.
    Wang MY; Peng L; Lutfiyya MN; Henley E; Weidenbacher-Hoper V; Anderson G
    Nutr Cancer; 2009; 61(5):634-9. PubMed ID: 19838937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
    Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
    Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits.
    Camoirano A; Bagnasco M; Bennicelli C; Cartiglia C; Wang JB; Zhang BC; Zhu YR; Qian GS; Egner PA; Jacobson LP; Kensler TW; De Flora S
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):775-83. PubMed ID: 11440963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
    Hsu TM; Zhang YJ; Santella RM
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-B[a]PDE-DNA formation in lymphomonocytes of humans environmentally exposed to polycyclic aromatic hydrocarbons].
    Pavanello S; Pulliero A; Lai A; Gaiardo A; Mastrangelo G; Clonfero E
    G Ital Med Lav Ergon; 2005; 27(3):312-4. PubMed ID: 16240582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.